TNF and atherosclerosis: Despite that a recent systematic review showed no significant effect of TNF-α inhibitors on the subclinical indicators of atherosclerosis in inflammatory diseases including psoriasis, a positive effect of TNF-α biologics on the clinical outcomes of CVDs via alternate pathways, such as primary disease remission or reduced prothrombotic tendency, cannot be ruled out (Knowles et al., 2020).